<DOC>
	<DOCNO>NCT03052205</DOCNO>
	<brief_summary>This Phase 1b study incorporates dose expansion cohort evaluate promise clinical biological activity .</brief_summary>
	<brief_title>A Study Intratumoral IMO-2125 Patients With Refractory Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Patients must histologically cytologically confirm diagnosis cancer amenable curative therapy . Patients diagnosis PD ( L ) 1 inhibitor FDA approve must previously receive treatment one therapy . Patients must disease measurable RECIST v1.1 least 2 tumor accessible biopsy . Patients must 18 year age old . Patients must ECOG Performance Status ≤2 . Patients must meet follow laboratory criterion : 1 . ANC ≥1.5 x 109/L ( ≥1500/mm3 ) 2 . Platelet count ≥100 x 109/L ( ≥100,000/mm3 ) 3 . Hemoglobin ≥8.0 g/dL ( ≥4.96 mmol/L ) 4 . Serum creatinine ≤1.5 x ULN 24hour creatinine clearance ≥60 mL/minute 5 . AST ≤2.5 x ULN ; ALT ≤2.5 x ULN AST/ALT &lt; 5 x ULN liver involvement 6 . Serum bilirubin ≤1.5 x ULN , except patient Gilbert 's Syndrome must total bilirubin &lt; 3 mg/dL ( 51.3 μmol/L ) Patients receive prior therapy TLR agonist ( prior treatment topical TLR agonist ( e.g . imiquimod ) permit ) . Patients receive treatment IFNα within previous 6 month prior enrollment . Patients know hypersensitivity oligodeoxynucleotide adequately manage appropriate prophylaxis . Patients active autoimmune disease require diseasemodifying therapy . Patients require concurrent systemic steroid therapy high physiologic dosage ( 7.5 mg/day prednisone equivalent ) . Patients another primary malignancy remission least 3 year . The following exempt 3year limit : nonmelanoma skin cancer , curatively treat localized prostate cancer nondetectable prostatespecific antigen , cervical carcinoma situ biopsy squamous intraepithelial lesion Papanicolaou ( Pap ) smear , thyroid cancer ( except anaplastic ) . Patients active infection require systemic treatment . Patients know hepatitis B surface antigen positive . Patients know diagnosis human immunodeficiency virus ( HIV ) infection . Women pregnant breastfeeding . Patients known central nervous system , meningeal , epidural disease . Patients stable brain metastasis follow definitive local treatment eligible steroid requirement &lt; 7.5 mg/day prednisone ( equivalent ) . Patients impaired cardiac function clinically significant cardiac disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>